PEGINTERFERON ALFA-2B (ANTI-CANCER) - INJECTION
PHONETIC PRONUNCIATION: (peg-IN-ter-FEER-on AL-fa too bee)
COMMON BRAND NAME(S): Sylatron
GENERIC NAME(S): peginterferon alfa-2b
Uses
USES: This medication is used to keep malignant melanoma (a type of skin cancer) from coming back after it has been removed by surgery. This medication is the same as a protein that your body naturally makes (interferon). This medication is thought to work by affecting how cells work and grow and by affecting the body's natural defenses (immune system) in many ways. Adding more interferon may help your body fight off cancer.
How to use PEGINTERFERON ALFA-2B (ANTI-CANCER) - INJECTION
HOW TO USE: Read the Medication Guide and the Instructions for Use Leaflet provided by your pharmacist before you start using peginterferon alfa-2b and each time you get a refill. If you have any questions, ask your doctor, nurse or pharmacist. If you are giving this medication to yourself at home, learn all preparation and usage instructions from your health care professional. Gently swirl the vial to dissolve the medication. Do not shake the vial. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely. Before injecting each dose, clean the injection site with rubbing alcohol. Use a different place each time you give yourself an injection to help lessen injection site soreness. Inject this medication under the skin (subcutaneously) on your thigh, stomach, or the outer surface of your upper arm, as directed by your doctor, usually once weekly. Do not inject near the belly button or at the waistline. The dosage is based on your body weight, medical condition, and response to treatment. Use this medication regularly to get the most benefit from it. Remember to use it on the same day each week. It may help to mark your calendar with a reminder. If you have flu-like symptoms, drink plenty of fluids while you are using this medication, unless your doctor directs you otherwise.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for PEGINTERFERON ALFA-2B (ANTI-CANCER) - INJECTION
Peginterferon alfa-2b is a medication used to treat certain types of cancer, including melanoma and follicular lymphoma. It belongs to a class of drugs called interferons that help the body's immune system fight cancer cells.
Peginterferon alfa-2b is given as an injection under the skin (subcutaneously) or into a muscle (intramuscularly). The specific dosage and administration schedule will be determined by your healthcare provider.
Common side effects of peginterferon alfa-2b include flu-like symptoms (fever, chills, muscle aches), fatigue, headache, nausea, vomiting, diarrhea, and injection site reactions. It is important to discuss any side effects with your doctor.
The duration of treatment with peginterferon alfa-2b will vary depending on the specific type and stage of cancer being treated. Your healthcare provider will determine the appropriate treatment plan for you.
Peginterferon alfa-2b may interact with certain medications, including antiviral drugs and immunosuppressants. It is important to inform your doctor about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. You should also discuss any underlying medical conditions you have or if you are pregnant or breastfeeding.
It is generally recommended to avoid or limit alcohol consumption while taking peginterferon alfa-2b. Alcohol can worsen certain side effects of the medication and may also interact with the liver, which can be affected by peginterferon alfa-2b.
The effectiveness of peginterferon alfa-2b in treating cancer will vary depending on individual factors, such as the type and stage of cancer being treated. It is important to discuss the potential benefits and risks of treatment with your doctor.
Peginterferon alfa-2b is generally not recommended for use in children, as its safety and effectiveness in pediatric populations have not been well studied. However, in some cases, pediatric oncologists may prescribe it "off-label" if they determine potential benefits outweigh the risks. This decision will be made on a case-by-case basis.
Coverage for peginterferon alfa-2b will depend on your specific insurance plan. It is recommended to contact your insurance provider to determine coverage details and if any prior authorization is required.
Warning
WARNING: Peginterferon alfa-2b may cause you to develop serious mental/mood changes during treatment and up to 6 months after your last dose of the medication. Tell your doctor right away if you have symptoms such as confusion, depression, thoughts of suicide or hurting others, unusual irritability, or aggressive behavior. Your doctor may recommend psychiatric therapy and monitoring. Treatment with this medication may be stopped if symptoms are severe. However, these symptoms may not go away even after stopping the medication.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet